In early studies, TIM-3 was reported to have an inhibitory function, suppressing effector Th1 responses in EAE and type I diabetes in a mouse model, and the use of an anti-TIM-3 antibody was reported to lead to disease exacerbation in EAE (46). The gene discussed is HAVCR2; the disease is type 1 diabetes mellitus.